Stevanato Group S.p.A. (NYSE:STVN) Given Consensus Recommendation of "Moderate Buy" by Brokerages

Shares of Stevanato Group S.p.A. (NYSE:STVN - Get Free Report) have been assigned a consensus recommendation of "Moderate Buy" from the seven analysts that are currently covering the stock, Marketbeat reports. Two investment analysts have rated the stock with a hold recommendation and five have assigned a buy recommendation to the company.

STVN has been the topic of several research analyst reports. UBS Group cut their target price on Stevanato Group from $24.00 to $23.50 and set a "neutral" rating on the stock in a research report on Friday, March 7th. William Blair reissued an "outperform" rating on shares of Stevanato Group in a report on Friday, March 7th.

Stevanato Group Stock Down 0.9 %

Shares of Stevanato Group stock traded down €0.20 ($0.23) on Thursday, reaching €21.88 ($24.93). 349,200 shares of the company were exchanged, compared to its average volume of 353,229. The stock's 50 day moving average price is €20.56 and its 200-day moving average price is €20.67. The company has a market cap of $6.63 billion, a P/E ratio of 46.55, a price-to-earnings-growth ratio of 7.18 and a beta of 0.52. Stevanato Group has a 1-year low of €16.56 ($18.87) and a 1-year high of €29.11 ($33.17). The company has a debt-to-equity ratio of 0.22, a current ratio of 1.81 and a quick ratio of 1.21.

Stevanato Group (NYSE:STVN - Get Free Report) last announced its quarterly earnings data on Thursday, March 6th. The company reported €0.20 ($0.23) earnings per share for the quarter, meeting analysts' consensus estimates of €0.20 ($0.23). The business had revenue of €352.68 million for the quarter, compared to analyst estimates of €346.26 million. Stevanato Group had a net margin of 10.47% and a return on equity of 9.86%. As a group, equities analysts forecast that Stevanato Group will post 0.5 EPS for the current year.

Institutional Trading of Stevanato Group

Large investors have recently bought and sold shares of the business. AMI Asset Management Corp purchased a new stake in shares of Stevanato Group in the fourth quarter valued at about $1,089,000. SG Americas Securities LLC raised its stake in Stevanato Group by 18.2% during the 4th quarter. SG Americas Securities LLC now owns 15,546 shares of the company's stock valued at $339,000 after acquiring an additional 2,389 shares during the last quarter. Jennison Associates LLC purchased a new stake in Stevanato Group during the 4th quarter valued at approximately $20,239,000. Conestoga Capital Advisors LLC grew its position in Stevanato Group by 5.3% in the 4th quarter. Conestoga Capital Advisors LLC now owns 8,082,996 shares of the company's stock valued at $176,128,000 after buying an additional 407,086 shares during the last quarter. Finally, Truist Financial Corp increased its stake in shares of Stevanato Group by 4.2% during the fourth quarter. Truist Financial Corp now owns 26,900 shares of the company's stock worth $586,000 after acquiring an additional 1,073 shares during the period.

Stevanato Group Company Profile

Stevanato Group S.p.A. engages in the design, production, and distribution of products and processes to provide integrated solutions for bio-pharma and healthcare industries in Europe, the Middle East, Africa, North America, South America, and the Asia Pacific. The company operates in two segments, Biopharmaceutical and Diagnostic Solutions; and Engineering.